Review of osmotic pressure driven release of proteins from monolithic devices

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 10, Issue 2, 2007, Pages 129-143

  Amsden, Brian ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ATRIOPEPTIN III; CARBONATE DEHYDRATASE; CYTOKINE; DIMETICONE; GAMMA INTERFERON; GENTAMICIN; GROWTH FACTOR; HEPARIN LYASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; LIPOSOME; LYSOZYME; MICROSPHERE; OVALBUMIN; PILOCARPINE; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; PROTEIN; PROTEIN C; SODIUM IODIDE; TRYPSIN; VASCULOTROPIN;

BIODEGRADATION; CONTROLLED DRUG RELEASE; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; ENCAPSULATION; LIPOSOMAL DELIVERY; LONG TERM CARE; LOW DRUG DOSE; MATHEMATICAL MODEL; OSMOTIC PRESSURE; PATIENT COMPLIANCE; PH; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STABILITY; REVIEW; SUSTAINED RELEASE FORMULATION;

ANIMALS; DRUG DELIVERY SYSTEMS; MODELS, CHEMICAL; OSMOTIC PRESSURE; POLYMERS; PROTEINS;

EID: 34249337735     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. V. Lee, Peptide and protein drug delivery systems. Biopharm, March 24-31, 1988.
2. S. Frokjaer and D. E. Otzen, Protein drug stability: A formulation challenge. Nature Reviews Drug Discovery, 4(4): 298-306, 2005.
3. R. Rader, Biopharmaceutical Approvals Review. Genetic and Engineering News, August 70-74, 2006.
4. A. K. Pavlou and J. M. Reichert, Recombinant protein therapeutics - success rates, market trends and values to 2010. Nature Biotechnology, 22(12): 1513, 2004.
5. J. L. Cleland, M. F. Powell and S. J. Shire, The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Critical Rev. Therap. Drug Carrier Sys., 10(4): 307-377, 1993.
6. V. H. L. Lee, Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs, in Peptide and Protein Drug Delivery, V. H. L. Lee, Editor. 1991, Marcel Dekker: New York. p. 1-56.
7. R. Langer, Bioavailability of macromolecular drugs and its control, in Controlled Drug Bioavailability. 1985. p. 307-363.
8. M. L. van Slooten, G. Storm, A. Zoephel, Z. Kupcu, O. Boerman, D. J. A. Crommelin, E. Wagner and R. Kircheis, Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm. Res., 17(l): 42-48, 2000.
9. H. Yu and D. W. Grainger, Modified release of hydrophilic, hydrophobic and peptide agents from ionized amphiphilic gel networks. J. Control. Release, 34 117-127, 1995.
10. K. Fujioka, Y. Takada, S. Sato and T. Miyata, Novel delivery system for proteins using collagen as a carrier material: the minipellet. J. Control. Release, 33 307-315, 1995.
11. S. Takada, Y. Uda, H. Toguchi and Y. Ogawa, Preparation and characterization of copoly(dl-lactic/glycolic acid) microparticles for sustained release of thyrotropin releasing hormone by double nozzle spray drying method. J. Control. Release, 32 79-85, 1994.
12. R. C. Mehta, B. C. Thanoo and P. P. Deluca, Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide). J. Control. Release, 41(249-257), 1996.
13. H. Sah, R. Toddywala and Y. W. Chien, Continuous release of proteins from biodegradable microcapsules and in-vivo evaluation of their potential as a vaccine adjuvant. J Control Release, 35(2-3): 137-144, 1995.
14. M. van de Weert, W. E. Hennink and W. Jiskoot, Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res., 17(10): 1159-1167, 2000.
15. A. Gopferich, R. Gref, Y. Minamitake, L. Shieh, M. J. Alonso, Y. Tabata and R. Langer, Drug Delivery From Bioerodible Polymers: Systemic and Intravenous Administration, in Formulation and Delivery of Proteins and Peptides, J. L. Cleland and R. Langer, Editors. 1994, ACS: Washington.
16. K. Mader, B. Gallez, K. J. Liu and H. M. Swartz, Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials, 17(4): 457-461, 1996.
17. K. Fu, D. W. Pack, A. M. Klibanov and R. Langer, Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res., 17(l): 100-106, 2000.
18. A. Shenderova, T. G. Burke and S. P. Schwendeman, Evidence for an acidic microclimate in PLGA microspheres, in Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 1998, Controlled Release Society: LAs Vegas. p. 265-266.
19. L. Chen, R. N. Apte and S. Cohen, Characterization of PLGA microspheres for the controlled delivery of IL- 1alpha for tumor immunotherapy. J. Control. Release, 43(2-3): 261-272, 1997.
20. J. Yang and J. L. Cleland, Factors affecting the in vitro release of recombinant human interferon-g from PLGA microspheres. J. Pharm. Sci., 86(8): 908-914, 1997.
21. T. G. Park, W. Lu and G. Crotts, Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Release, 33(2): 211-222, 1995.
22. R. E. Johnson, L. A. Lanaski, V. Gupta, M. J. Griffm, H. T. Gaud, T. E. Needham and H. Zia, Stability of atriopeptin-III in poly(D,L-Lactide-co-glycolide) microspheres. J. Control. Release, 17(1): 61-67, 1991.
23. H. Takahata, E. C. Lavelle, A. G. A. Coombes and S. S. Davis, The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. J. Control. Release, 50(1-3): 237-246, 1998.
24. M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie and C. Vigneron, Preparation and characterization of protein C-loaded PLA nanoparticles. J. Control. Release, 60 179-188, 1999.
25. Y. Tabata, S. Gutta and R. Langer, Controlled delivery systems for proteins using polyanhydride microspheres. Pharmaceutical Research, 10(4): 487-496, 1993.
26. M. S. Hora, R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley and M. E. Hudson, Controlled release of interleukin-2 from biodegradable microspheres. Biotechnology, 8 755-758, 1990.
27. A. Aubert-Pouessel, D. C. Bibby, M.-C. Venier-Julienne, F. Hindre and J.-P. Benoit, A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm. Res., 19(7): 1046-1051, 2002.
28. G. Z. Zhu, S. R. Mallery and S. P. Schwendeman, Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotechnology, 18(l): 52-57, 2000.
29. L. Li and S. P. Schwendeman, Mapping neutral microclimate pH in PLGA microspheres. J. Control Release, 101 163-173, 2005.
30. M. Houchin, S. Neuenswander and E. Topp, Effect of excipients on PLGA film degradation and the stability of an incorporated peptide. J Control Release, accepted, 2006.
31. V. Carelli, G. Di Colo, C. Guerrini and E. Nannipieri, Drug release from silicone elastomer through controlled polymer cracking: An extension to macromolecular drugs. Int J Pharm, 50(3): 181-188, 1989.
32. G. Di Colo, Controlled drug release from implantable matrices based on hydrophobic polymers. Biomaterials, 13(12): 850-856, 1992.
33. R. Gale, S. K. Chandrasekaran, D. Swanson and J. Wright, Use of osmotically active therapeutic agents in monolithic systems. J. Membrane Sci., 7(3): 319-331, 1980.
34. M. Kajihara, T. Sugie, M. Mizuno, N. Tamura, A. Sano, K. Fujioka, Y. Kashiwazaki, T. Yamaoka, S. Sugawara and Y. Urabe, Development of a new drug delivery system for protein drugs using silicone (I). J. Control. Release, 66 49-61, 2000.
35. M. Kajihara, T. Sugie, T. Hojo, H. Maeda, A. Sano, K. Fujioka, S. Sugawara and Y. Urabe, Development of a new drug delivery system for protein drugs using silicone (II). J. Control. Release, 73 279-291, 2001.
36. J. Wright, S. K. Chandrasekaran, R. Gale and D. Swanson, Model for the release of osmotically active agents from monolithic polymeric matrices. AIChE Symp. Ser., 77(206), 1981.
37. B. G. Amsden and Y. L. Cheng, Enhanced fraction releasable above percolation threshold from monoliths containing osmotic excipients. J. Control. Release, 31(l): 21-32, 1994.
38. B. Amsden and Y. L. Cheng, A generic protein delivery system based on osmotically rupturable monoliths. J. Control. Release, 33(1): 99-105, 1995.
39. A. S. Michaels and M. S. Guillod, Osmotic bursting drug delivery device, US patent, 4,117,256 (1979).
40. J. W. McGinity, L. A. Hunke and A. B. Combs, Effect of water-soluble carriers on morphine release from a silicone polymer. J. Pharm. Sci., 68(5): 662-664, 1979.
41. G. Golomb, P. Fisher and E. Rahamim, The relationship between drug release rate, particle size and swelling of silicone matrices. J. Control. Release, 12(2): 121-132, 1990.
42. R. Schirrer, P. Thepin and G. Torres, Water absorption, swelling, rupture and salt release in saltsilicone rubber compounds. J. Mater. Sci., 27 3424-3434, 1992.
43. F. Marson, Anti-fouling paints: I Theoretical approach to leaching of soluble pigments from insoluble paint vehicles. J. Appl. Chem., 19 93-99, 1969.
44. N. Narkis and M. Narkis, Slow release of watersoluble salts from polymers. J Appl Polym Sci, 20 3431-3436, 1976.
45. R. F. Fedors, Osmotic effects in water absorption by polymers. Polymer, 21 207-212, 1980.
46. P. D. Riggs, P. Kinchesh, A Braden and M. P. Patel, Nuclear magnetic imaging of an osmotic water uptake and delivery process. Biomaterials, 22 419-427, 2001.
47. F. Marson, Antifouling paints II. A more detailed examination of the effect of pigment volume concentration. Journal of applied chemical biotechnology, 24 515-527, 1974.
48. B. Amsden, Osmotically activated protein release from electrostatically generated polymer microbeads. AIChE J., 42 3253-3266, 1996.
49. V. Carelli, G. Dicolo and E. Nannipieri, Factors in zero-order release of clonidine hydrochloride from monolithic polydimethylsiloxane matrices. Int J Pharm, 35(1-2): 21-28, 1987.
50. B. G. Amsden, Y. L. Cheng and M. F. A. Goosen, A mechanistic study of the release of osmotic agents from polymeric monoliths. J. Control. Release, 30(l): 45-56, 1994.
51. X. Zhang, U. Wyss, D. Pichora and M. F. A. Goosen, A mechanistic study of antibiotic release from biodegradable poly(d,l-lactide) cylinders. J Control Release, 31 129-144, 1994.
52. B. Amsden, A model for osmotic pressure driven release from cylindrical rubbery polymer matrices. J. Control. Release, 93 249-258, 2003.
53. R. Siegel, J. Kost and R. Langer, Mechanistic studies of macromolecular drug release from macroporous polymers. I. Experiments and preliminary theory concerning completeness of drug release. J. Control. Release, 8(3): 223-236, 1989.
54. V. L. Vilker, C. K. Colton and K. A. Smith, The osmotic pressure of concentrated protein solutions: Effect of concentration and pH in saline solutions of Bovine Serum Albumin. J. Coll. Int. Sci., 79(2): 548-566, 1981.
55. J. M. Kemp, M. Kajihara, S. Nagahara, A. Sano, M. Brandon and S. Lofthouse, Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses. Vaccine, 20(7-8): 1089, 2002.
56. C. Aschkenasy and J. Kost, On-demand release by ultrasound from osmotically swollen hydrophobic matrices. J Control Release, 110(l): 58, 2005.
57. B. G. Amsden, M. Y. Tse, N. D. Turner, D. K. Knight and S. C. Pang, In vivo degradation behavior of photo-cross-linked star-poly(epsilon-caprolactone-co-D,L-lactide) elastomers. Biomacromolecules, 7(l): 365, 2006.
58. F. Gu, R. J. Neufeld and B. Amsden, Osmotic driven release kinetics of bioactive therapeutic proteins from a biodegradable elastomer are linear, constant, similar and adjustable. Pharm Res, 23(4): 782-789, 2006.
59. F. Gu, R. Neufeld and B. Amsden, Sustained release of bioactive therapeutic proteins from a biodegradable elastomeric device. J Control Release, accepted.
60. M. Mulkerrin and R. Wetzel, pH-dependence of the reversible and irreversible thermal-denaturation of gamma-interferons. Biochemistry-US, 28(16): 6556-6561, 1989.
61. M. S. Ricci, C. A. Sarkar, E. M. Fallon, D. A. Lauffenburger and D. N. Brems, pH Dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor. Protein Science, 12(5): 1030-1038, 2003.
62. C. Goolcharran, J. L. Cleland, R. Keck, A. J. S. Jones and R. T. Borchardt, Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptides. AAPS Pharmsci, 2(l), 2000.
63. A. Sharma and U. S. Sharma, Liposomes in drug delivery: progress and limitations. Int. J. Pharm., 154 123-140, 1997.
64. T. Thomas, D. Kohane, A. Wang and R. Langer, Microparticulate formulations for the controlled release of interleukin-2. J Pharm Sci, 93(5): 1100-1109, 2004.
65. K. J. Zhu, R. W. Hendren, K. Jensen and C. G. Pitt, Synthesis, properties, and biodegradation of poly(1,3-trimethylene carbonate). Macromolecules, 24 1736-1740, 1991.
66. E. Ruckenstein and Y. M. Yuan, Molten ring-open copolymerization of L-lactide and cyclic trimethylene carbonate. J Appl Polym Sci, 69(7): 1429-1434, 1998.
67. D. W. Grijpma and A. J. Pennings, (Co)Polymers of L-Lactide.l. Synthesis, Thermal-Properties and Hydrolytic Degradation. Macromol Chem Phys, 195(5): 1633-1647, 1994.
68. C. Jie, K. J. Zhu and S. L. Yang, Preparation, characterization and biodegradable characteristics of poly(1,3-trimethylene carbonate-co-glycolide). Polymer Int, 41(4): 369-375, 1996.
69. C. Jie and K. J. Zhu, Preparation, characterization and biodegradable characteristics of poly(D,L-lactide-co1,3-trimethylene carbonate). Polymer Int, 42(4): 373-379, 1997.
70. A. P. Pego, A. A. Poot, D. W. Grijpma and J. Feijen, Copolymers of trimethylene carbonate and epsilon-caprolactone for porous nerve guides: Synthesis and properties. J Biomater Sci Polym Edn, 12(1): 35-53, 2001.
71. J. Cai, K. J. Zhu and S. L. Yang, Surface biodegradable copolymers - poly(D,L-lactide-co-1-methyl-1,3-trimethylene carbonate) and poly(D,L-lactide-co-2,2-dimethyl-1,3-trimethylene carbonate): preparation, characterization and biodegradation characteristics in vivo. Polymer, 39(18): 4409-4415, 1998.
72. A. P. Pego, M. J. A. Van Luyn, L. A. Brouwer, P. B. van Wachem, A. A. Poot, D. W. Grijpma and J. Feijen, In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response. J Biomed Mater Res A, 67A(3): 1044-1054, 2003.
73. F. Gu, H. M. Younes, A. O. S. El-Kadi, R. J. Neufeld and B. G. Amsden, Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer. J Control Release, 102(3): 607-617, 2005.